Elpen Pharmaceutical Co. Inc.
Budget
€25 — €0
EP Access
0
accredited persons
Staff
10
1 FTE
EU Grants
None
Mission & Goals
ELPEN is a leading Greek private pharmaceutical company, founded in 1965, with more than 1200 employees and annual turnover of € 250M. With state of the art production and research facilities, ELPEN specializes in the development, production and commercialization of generic products and value added medicines, exporting to more than 60 countries worldwide. The company's vision is to actively contribute to advancing health services, while its mission is to create effective treatments that enhance patients' lives worldwide. ELPEN is a member of Medicines for Europe, the European association representing generics, biosimilar and added value medicines. As acting stakeholders both at European and National level, we believe that our company is uniquely positioned to provide feedback and proposals regarding challenges and policy proposals regarding Europe.
EU Legislative Interests
Elpen follows all European Public Health Policy Developments. Our priority is currently the review of the general pharmaceutical legislation.
Communication Activities
Elpen is active at European level and attending events organized by the European association Medicines for Europe.
Interests Represented
Promotes their own interests or the collective interests of their members
Member Of
Medicines for Europe (www.medicinesforeurope.com) Critical Medicines Alliance Panhellenic Union of Pharmaceutical Industries (PEF, www.pef.gr)
Organisation Members
Hellenic Federation of Enterprises (SEV, www.sev.org.gr)
Commissioner Meetings
No recorded meetings with EU commissioners.